| Literature DB >> 29452670 |
Abstract
CLL is the most common leukemia in older adults with a median age at diagnosis of 71. Therefore, management of patients with this disease must take into account the older age of most patients and consequences of this in terms of functional status and organ function. This review will discuss the management of CLL with regards to observation prior to the initiation of therapy, functional status, and initial treatment. We will discuss criteria for the initiation of therapy, and how initial therapy is different between older and younger patients. Finally, we will discuss specific therapies including chemoimmunotherapy and newer targeted therapies that are being used widely in the older patient population.Entities:
Keywords: Chronic lymphocytic leukemia; Elderly; Geriatric assessment; Targeted therapies
Mesh:
Year: 2017 PMID: 29452670 DOI: 10.1016/j.beha.2017.10.007
Source DB: PubMed Journal: Best Pract Res Clin Haematol ISSN: 1521-6926 Impact factor: 3.020